What are the efficacy and safety of bisphosphonates and RANK-ligand-inhibitors for men with prostate cancer and bone metastases? - A Cochrane Review summary with commentary

被引：0
|
作者：
Moretti, Antimo [1 ]
机构：
[1] Univ Campania Luigi Vanvitelli, Dept Med & Surg Specialties & Dent, Caserta, Italy
来源：
JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS | 2021年 / 21卷 / 04期
关键词：
Bisphosphonates; Cochrane; Denosumab; Metastasis; Rehabilitation; DENOSUMAB; PAIN;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：451 / 454
页数：4
相关论文
共 50 条
  • [1] Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: A Cochrane review and network meta-analysis
    Tesfamariam, Y. M.
    Jakob, T.
    Macherey, S.
    Monsef, I
    Heidenreich, A.
    Becker, I
    Kuhr, K.
    Skoetz, N.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 326 - 326
  • [2] Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis
    Jakob, Tina
    Tesfamariam, Yonas Mehari
    Macherey, Sascha
    Kuhr, Kathrin
    Adams, Anne
    Monsef, Ina
    Heidenreich, Axel
    Skoetz, Nicole
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (12):
  • [3] Bisphosphonates or RANK Ligand Inhibitors for Men with Prostate Cancer and Bone Metastases: Commentary on Network Meta-Analysis
    Draeger, Desiree L.
    [J]. UROLOGIE, 2022, 61 (08): : 855 - 859
  • [4] Adjuvant bisphosphonates or RANK-ligand-inhibitors for patients with breast cancer and bone metastases: A systematic review and network meta-analysis
    Tesfamariam, Y. M.
    Jakob, T.
    Woeckel, A.
    Monsef, I.
    Kuhr, K.
    Skoetz, N.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 160 - 160
  • [5] Bisphosphonates or RANK-ligand inhibitors for patients with solid cancer and bone metastases or multiple myeloma: a systematic Cochrane review and meta-analysis
    Koehler, N.
    Jordan, K.
    Jahn, F.
    Woermann, B.
    Skoetz, N.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 164 - 164
  • [6] The effect of radiotherapy, and radiotherapy combined with bisphosphonates or RANK ligand inhibitors on bone quality in bone metastases. A systematic review
    Groenen, Karlijn H. J.
    Pouw, Martin H.
    Hannink, Gerjon
    Hosman, Allard J. F.
    van der Linden, Yvette M.
    Verdonschot, Nico
    Tanck, Esther
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 (02) : 194 - 201
  • [7] Adjuvant bisphosphonates or RANK-ligand inhibitors for patients with breast cancer and bone metastases: A systematic review and network meta-analysis
    Tesfamariam, Y.
    Jakob, T.
    Woeckel, A.
    Adams, A.
    Weigl, A.
    Monsef, I.
    Kuhr, K.
    Skoetz, N.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 137 : 1 - 8
  • [8] Safety and efficacy of exercise by prostate cancer survivors with bone metastases
    Cormie, Prue
    Newton, Robert
    Spry, Nigel
    Joseph, David
    Galvao, Daniel
    [J]. BJU INTERNATIONAL, 2013, 112 : 62 - 62
  • [9] What is the efficacy of family approaches in the treatment of people with anorexia nervosa?: A Cochrane Review summary with commentary
    Pepin, Genevieve
    [J]. AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL, 2021, 68 (05) : 472 - 474
  • [10] Efficacy and safety of intravenous bisphosphonates in patients with bone metastases caused by metastatic breast cancer
    Lipton, Allan
    [J]. CLINICAL BREAST CANCER, 2007, 7 : S14 - S20
12345